Prostate cancer study
A BREAST cancer drug could also be used to stop prostate cancer returning, a study has found.
The drug acts by stopping tumours carrying out repairs to their own DNA, causing the cancer to become weak and die.
One of the ways prostate cancer currently gets treated is through therapy that reduces SCIENTISTS have identified a new way of spotting men most at risk of ill health – by testing their semen.
The team found young men with the lowest sperm counts had higher rates of heart disease, diabetes and cancer later in life.
Researchers at Frederiksberg Hospital in Denmark tracked 4 700 men for 30 years. Those with sperm counts lower than 15 million per millilitre of fluid were 40% more likely to get heart disease than those registering hormones which encourage the growth of cancer cells – but this also stimulates a repair mechanism that can lead to surviving cells becoming more aggressive. However, researchers found that breast cancer drugs called Parp inhibitors, used with anti-hormone treatment, can stop the repair effect. The study, by more than 40 million per millilitre.
They needed hospital care, on average, seven years earlier than men with healthy sperm counts, the results of the study, published the Institute of Cancer Research, carried out the tests on human prostate cancer tissue.
Lead author Dr Mohammad Asim said: “Prostate cancer is a devastating disease. Our exciting discovery will increase chances of survival for the thousands of men who contract the disease every year.” – Daily Mail in the American Journal of Epidemiology, showed. Low sperm count can reflect poor diet and lifestyle, which increases the risk of serious illness. – Daily Mail